HSPT Postpones Shareholder Meeting, Extends Redemption Deadline
Biotechnology
Extension
Merger:
Jun 15, 2026
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Show Chart?
Load external content from TradingView!
*You can change or withdraw your consent at any time in the footer under Cookies.
Horizon Space Acquisition II Corp. Postpones Shareholder Meeting and Extends Redemption Deadline
New York, NY, USA - Horizon Space Acquisition II Corp. (NASDAQ: HSPT) announced on January 30, 2026, that it has postponed its extraordinary general meeting and extended the deadline for redemption requests. The decision was made to allow the Company additional time to engage with its shareholders regarding the proposed business combination with SL BIO Ltd.
... Read on — Members only
About SL Science Holding Ltd
SL Bio is a biomedical company focused on developing innovative cellular and gene therapies for cancer treatment and regenerative medicine. Leveraging proprietary technologies and strategic partnerships, the company is advancing next-generation immunotherapies and exosome-based products for both medical and consumer applications. SL Bio’s approach combines scientific expertise with a commitment to improving patient outcomes and addressing unmet needs in healthcare. SL Bio also offers ISO-certified, dermatologically tested cow milk-derived exosome-based products and plant extract products for skin and hair care, with commercial distribution in Asia.
